Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse Effects

Objective To compare the therapeutic and adverse effects of globus pallidus interna (GPi) and subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of advanced Parkinson’s disease (PD). Methods We retrospectively analyzed the clinical data of patients with PD who underwent GPi (n...

Full description

Bibliographic Details
Main Authors: Ho-Sung Ryu, Mi-Sun Kim, Sooyeoun You, Mi-Jung Kim, Young Jin Kim, Juyeon Kim, Kiju Kim, Sun Ju Chung
Format: Article
Language:English
Published: Korean Movement Disorder Society 2017-05-01
Series:Journal of Movement Disorders
Subjects:
Online Access:http://www.e-jmd.org/upload/jmd-17001.pdf
_version_ 1797760926965825536
author Ho-Sung Ryu
Mi-Sun Kim
Sooyeoun You
Mi-Jung Kim
Young Jin Kim
Juyeon Kim
Kiju Kim
Sun Ju Chung
author_facet Ho-Sung Ryu
Mi-Sun Kim
Sooyeoun You
Mi-Jung Kim
Young Jin Kim
Juyeon Kim
Kiju Kim
Sun Ju Chung
author_sort Ho-Sung Ryu
collection DOAJ
description Objective To compare the therapeutic and adverse effects of globus pallidus interna (GPi) and subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of advanced Parkinson’s disease (PD). Methods We retrospectively analyzed the clinical data of patients with PD who underwent GPi (n = 14) or STN (n = 28) DBS surgery between April 2002 and May 2014. The subjects were matched for age at surgery and disease duration. The Unified Parkinson’s Disease Rating Scale (UPDRS) scores and levodopa equivalent dose (LED) at baseline and 12 months after surgery were used to assess the therapeutic effects of DBS. Adverse effects were also compared between the two groups. Results At 12 months, the mean changes in the UPDRS total and part I–IV scores did not differ significantly between the two groups. However, the subscores for gait disturbance/postural instability and dyskinesia were significantly more improved after GPi DBS than those after STN DBS (p = 0.024 and 0.016, respectively). The LED was significantly more reduced in patients after STN DBS than that after GPi DBS (p = 0.004). Serious adverse effects did not differ between the two groups (p = 0.697). Conclusion The patients with PD showed greater improvement in gait disturbance/postural instability and dyskinesia after GPi DBS compared with those after STN DBS, although the patients had a greater reduction in LED after STN DBS. These results may provide useful information for optimal target selection for DBS in PD.
first_indexed 2024-03-12T19:05:35Z
format Article
id doaj.art-c34c5a7c80cb436f9a5825751730f8ea
institution Directory Open Access Journal
issn 2005-940X
2093-4939
language English
last_indexed 2024-03-12T19:05:35Z
publishDate 2017-05-01
publisher Korean Movement Disorder Society
record_format Article
series Journal of Movement Disorders
spelling doaj.art-c34c5a7c80cb436f9a5825751730f8ea2023-08-02T06:17:01ZengKorean Movement Disorder SocietyJournal of Movement Disorders2005-940X2093-49392017-05-01102808610.14802/jmd.17001191Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse EffectsHo-Sung Ryu0Mi-Sun Kim1Sooyeoun You2Mi-Jung Kim3Young Jin Kim4Juyeon Kim5Kiju Kim6Sun Ju Chung7 Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Neurology, Dongsan Medical Center, Keimyung University, Daegu, Korea Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea Department of Neurology, Best Heals Hospital, Ansan, Korea Department of Neurology, Metro Hospital, Anyang, Korea Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaObjective To compare the therapeutic and adverse effects of globus pallidus interna (GPi) and subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of advanced Parkinson’s disease (PD). Methods We retrospectively analyzed the clinical data of patients with PD who underwent GPi (n = 14) or STN (n = 28) DBS surgery between April 2002 and May 2014. The subjects were matched for age at surgery and disease duration. The Unified Parkinson’s Disease Rating Scale (UPDRS) scores and levodopa equivalent dose (LED) at baseline and 12 months after surgery were used to assess the therapeutic effects of DBS. Adverse effects were also compared between the two groups. Results At 12 months, the mean changes in the UPDRS total and part I–IV scores did not differ significantly between the two groups. However, the subscores for gait disturbance/postural instability and dyskinesia were significantly more improved after GPi DBS than those after STN DBS (p = 0.024 and 0.016, respectively). The LED was significantly more reduced in patients after STN DBS than that after GPi DBS (p = 0.004). Serious adverse effects did not differ between the two groups (p = 0.697). Conclusion The patients with PD showed greater improvement in gait disturbance/postural instability and dyskinesia after GPi DBS compared with those after STN DBS, although the patients had a greater reduction in LED after STN DBS. These results may provide useful information for optimal target selection for DBS in PD.http://www.e-jmd.org/upload/jmd-17001.pdfParkinson’s diseasedeep brain stimulationglobus pallidus internasubthalamic nucleus.
spellingShingle Ho-Sung Ryu
Mi-Sun Kim
Sooyeoun You
Mi-Jung Kim
Young Jin Kim
Juyeon Kim
Kiju Kim
Sun Ju Chung
Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse Effects
Journal of Movement Disorders
Parkinson’s disease
deep brain stimulation
globus pallidus interna
subthalamic nucleus.
title Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse Effects
title_full Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse Effects
title_fullStr Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse Effects
title_full_unstemmed Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse Effects
title_short Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Therapeutic and Adverse Effects
title_sort comparison of pallidal and subthalamic deep brain stimulation in parkinson s disease therapeutic and adverse effects
topic Parkinson’s disease
deep brain stimulation
globus pallidus interna
subthalamic nucleus.
url http://www.e-jmd.org/upload/jmd-17001.pdf
work_keys_str_mv AT hosungryu comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects
AT misunkim comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects
AT sooyeounyou comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects
AT mijungkim comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects
AT youngjinkim comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects
AT juyeonkim comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects
AT kijukim comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects
AT sunjuchung comparisonofpallidalandsubthalamicdeepbrainstimulationinparkinsonsdiseasetherapeuticandadverseeffects